- Home
- NYMTZ vs CYCCP Comparison
NYMTZ vs CYCCP Comparison
Compare NYMTZ & CYCCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMTZ
- CYCCP
- Stock Information
- Founded
- NYMTZ N/A
- CYCCP N/A
- Country
- NYMTZ United States
- CYCCP United States
- Employees
- NYMTZ 79
- CYCCP 12
- Industry
- NYMTZ Real Estate Investment Trusts
- CYCCP Biotechnology: Pharmaceutical Preparations
- Sector
- NYMTZ Real Estate
- CYCCP Health Care
- Exchange
- NYMTZ Nasdaq
- CYCCP Nasdaq
- Market Cap
- NYMTZ N/A
- CYCCP N/A
- IPO Year
- NYMTZ N/A
- CYCCP N/A
- Fundamental
- Price
- NYMTZ $19.82
- CYCCP $6.94
- Analyst Decision
- NYMTZ
- CYCCP
- Analyst Count
- NYMTZ 0
- CYCCP 0
- Target Price
- NYMTZ N/A
- CYCCP N/A
- AVG Volume (30 Days)
- NYMTZ N/A
- CYCCP N/A
- Earning Date
- NYMTZ N/A
- CYCCP N/A
- Dividend Yield
- NYMTZ N/A
- CYCCP N/A
- EPS Growth
- NYMTZ N/A
- CYCCP N/A
- EPS
- NYMTZ N/A
- CYCCP N/A
- Revenue
- NYMTZ N/A
- CYCCP N/A
- Revenue This Year
- NYMTZ N/A
- CYCCP N/A
- Revenue Next Year
- NYMTZ N/A
- CYCCP N/A
- P/E Ratio
- NYMTZ N/A
- CYCCP N/A
- Revenue Growth
- NYMTZ N/A
- CYCCP N/A
- 52 Week Low
- NYMTZ N/A
- CYCCP N/A
- 52 Week High
- NYMTZ N/A
- CYCCP N/A
- Technical
- Relative Strength Index (RSI)
- NYMTZ 36.44
- CYCCP 50.02
- Support Level
- NYMTZ $19.45
- CYCCP $5.58
- Resistance Level
- NYMTZ $20.51
- CYCCP $7.07
- Average True Range (ATR)
- NYMTZ 0.34
- CYCCP 0.17
- MACD
- NYMTZ -0.05
- CYCCP 0.03
- Stochastic Oscillator
- NYMTZ 18.50
- CYCCP 70.83
About NYMTZ New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About CYCCP Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.